Trials / Completed
CompletedNCT01173965
Endometrial Ablation With Non-hysteroscopic Methods
Treatment of Dysfunctional Uterine Bleeding With Second Generation Ablation Devices: Microwaves (MEA®) vs Bipolar Impedance Control System (Novasure®)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 66 (actual)
- Sponsor
- Aristotle University Of Thessaloniki · Academic / Other
- Sex
- Female
- Age
- 30 Years – 49 Years
- Healthy volunteers
- Not accepted
Summary
Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates using Novasure are higher than those observed in microwave endometrial ablation, one year following intervention.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MEA | Microwave endometrial ablation device |
| DEVICE | Novasure | Bipolar impedence control system |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2010-02-01
- Completion
- 2011-02-01
- First posted
- 2010-08-03
- Last updated
- 2012-07-12
Locations
2 sites across 1 country: Greece
Source: ClinicalTrials.gov record NCT01173965. Inclusion in this directory is not an endorsement.